One of the challenges we face in Australia is getting more homegrown medtech products purchased and used by local hospitals and health services.

MTPConnect’s Pathway to Market – Medtech Capability Uplift Program has been supporting seven market-ready Victorian medtech innovations to position themselves competitively for local health procurement opportunities.

The recent Australian Medtech Manufacturing Alliance (AMMA) Medtech Showcase profiled Victorian-made products and innovations from 21 local manufacturers spanning surgical care and diagnostics to hospital consumables and equipment. From advanced lung imaging, a live patient monitoring system to solve pressure injury to a sophisticated AI screening tool to profile endometriosis, the lineup was impressive.

Companies were given the opportunity to pitch to a room full of health system leaders and procurement specialists, including representatives from HealthShares Victoria, Monash Health and Western Health.

The Showcase highlighted ‘Better Health Made Here’ – and the MTPConnect Podcast was on the ground talking to companies involved about getting procurement ready, including those taking part in the Pathway to Market Program – 4D Medical’s Professor Tim O’Meara, Lenexa Medical’s Ajit Ravindran and Arelis’ Tori Fox - as well as Akeeko Medical’s Professor Joseph Ischia.

The Pathway to Market program is an initiative of the Australian Medtech Manufacturing Alliance (AMMA), delivered by MTPConnect in partnership with BioMelbourne Network and supported by the Victorian Government. Victoria serves as the pilot state for this important, solutions-driven program, setting the foundation to drive a national agenda for medtech innovation and manufacturing, and get other states on board!